​

Funding Round

Series A - Seaport Therapeutics

Series A - Seaport Therapeutics

Investment Firm

Overview

Seaport Therapeutics operates as a clinical stage biopharmaceutical company.

Announced Date

Apr 09, 2024

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

ARCH Venture Partners

ARCH Venture Partners

ARCH Venture Partners is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Sofinnova Investments

Sofinnova Investments

Sofinnova Investments is a early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

4

Investor Name
Participant InvestorSofinnova Investments
Participant InvestorPureTech Health
Participant InvestorARCH Venture Partners
Participant InvestorThird Rock Ventures

Round Details and Background

Seaport Therapeutics raised $100000000 on 2024-04-09 in Series A

Seaport Therapeutics operates as a clinical stage biopharmaceutical company.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 09, 2024
Series A - Seaport Therapeutics
4-100.0M

Recent Activity

There is no recent news or activity for this profile.